The CARE Plus research project is part of the We Care Indy program and uses a unique, community-focused approach to helping new mothers and babies addicted to opioids. In 2014, more than 600 infants were born with neonatal abstinence syndrome in Indiana. Neonatal abstinence syndrome develops when a mother struggles with opioid dependence during pregnancy. The fetus is exposed to those opioids and goes through withdrawal after birth.
The goals of CARE Plus are to decrease infant mortality, improve the long-term health of mothers and babies and address the opioid crisis.
CARE Plus is offered at IU Health Methodist Hospital. When a baby is born at Methodist with neonatal abstinence syndrome, a therapist and community health worker meet the mother to inform her about the program. If the mother chooses to participate, the therapist and a community health worker continue meeting with the mother and baby while the baby is in the neonatal intensive care unit and teach the mother how to care for herself and her baby.
Once mother and baby leave the hospital, the community health worker continues to build relationships with the participating mother and other caregivers in the baby’s life. The community health worker acts as a support and connects the mother to resources she may need, such as food, clothing, housing, therapy and addiction recovery programs.
We Care App
The CARE Plus research program through Indiana University School of Medicine is funded, in part, by the Richard M. Fairbanks Foundation. The program is also receiving support from the Indiana Clinical and Translational Sciences Institute and the Indiana University Responding to the Addictions Crisis Grand Challenges initiative, the nation’s largest and most comprehensive university-led response to the opioid addiction crisis.